Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Immune Pharmaceuticals Inc (IMNPQ)

Immune Pharmaceuticals Inc (IMNPQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7
  • Shares Outstanding, K 7,100
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,890 K
  • 60-Month Beta 1.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade IMNPQ with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 10/01/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 +900.00%
on 08/03/22
0.0010 unch
on 08/16/22
unch (unch)
since 07/15/22
3-Month
0.0001 +900.00%
on 08/03/22
0.0010 unch
on 08/16/22
unch (unch)
since 05/12/22
52-Week
0.0001 +900.00%
on 08/03/22
0.0070 -85.71%
on 09/03/21
-0.0020 (-66.67%)
since 08/16/21

Most Recent Stories

More News
Acquisition of Immune Pharmaceuticals

Unconditional offer in relation to acquire the public entity FORT LEE, VA / ACCESSWIRE / March 29, 2021 / Immune Pharmaceuticals Inc's (IMNPQ), (FZRQ.F) has received an unconditional offer to take over...

IMNPQ : 0.0010 (unch)

Business Summary

Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Immune's lead program, bertilimumab, is a first-in-class, human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to...

See More

Key Turning Points

3rd Resistance Point 0.0010
2nd Resistance Point 0.0010
1st Resistance Point 0.0010
Last Price 0.0010
1st Support Level 0.0010
2nd Support Level 0.0010
3rd Support Level 0.0010

See More

52-Week High 0.0070
Fibonacci 61.8% 0.0044
Fibonacci 50% 0.0036
Fibonacci 38.2% 0.0027
Last Price 0.0010
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar